{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:47Z","timestamp":1790702207116,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijd.ijd_191_17","type":"journal-article","created":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T23:54:51Z","timestamp":1500854091000},"page":"395","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis"],"prefix":"10.4103","volume":"62","author":[{"given":"PRavindra","family":"Babu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J S","family":"Pravin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Dhoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Kotak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.210069-1","first-page":"2","volume-title":"Epidemiological trends in skin mycoses worldwide","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"key-10.4103\/0019-5154.210069-2","first-page":"21","volume-title":"Comparative study of different microscopic techniques and culture media for the isolation of dermatophytes","author":"Singh","year":"2003","journal-title":"Indian J Med Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0255-0857","issn-type":"print"},{"key":"key-10.4103\/0019-5154.210069-3","first-page":"49","volume-title":"Update on terbinafine with a focus on dermatophytoses","author":"Newland","year":"2009","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"key-10.4103\/0019-5154.210069-4","first-page":"179","volume-title":"Terbinafine.An update of its use in superficial mycoses","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"key-10.4103\/0019-5154.210069-5","first-page":"529","volume-title":"Relapse after oral terbinafine therapy in dermatophytosis: A clinical and mycological study","author":"Majid","year":"2016","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0019-5154.210069-6","first-page":"2840","volume-title":"Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine","author":"Osborne","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.210069-7","first-page":"2234","volume-title":"Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine","author":"Osborne","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.210069-8","first-page":"82","volume-title":"Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine","author":"Mukherjee","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.210069-9","first-page":"2219","volume-title":"Physiologically based pharmacokinetic model for terbinafine in rats and humans","author":"Hosseini-Yeganeh","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.210069-10","first-page":"212","volume-title":"Antifungal drugs and resistance: Current concepts.Our Dermatol Online","author":"PK","year":"2015","journal-title":""},{"key":"key-10.4103\/0019-5154.210069-11","first-page":"372","volume-title":"Update on antifungal resistance","author":"Klepser","year":"1997","journal-title":"Trends Microbiol"},{"key":"key-10.4103\/0019-5154.210069-12","first-page":"393","volume-title":"An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis","author":"Jaiswal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.210069-13","first-page":"11","volume-title":"Emerging threats in antifungal-resistant fungal pathogens","author":"Sanglard","year":"2016","journal-title":"Front Med (Lausanne)"},{"key":"key-10.4103\/0019-5154.210069-14","first-page":"382","volume-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0019-5154.210069-15","first-page":"501","volume-title":"Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","author":"Ghannoum","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0019-5154.210069-16","first-page":"48","volume-title":"Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: Investigating optimal dosing regimens using a physiologically based pharmacokinetic model","author":"Dolton","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0019-5154.210069-17","first-page":"1537","volume-title":"A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis","author":"Cole","year":"1989","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.210069-18","first-page":"243","volume-title":"A comparative study of terbinafine versus griseofulvin in 'dry-type' dermatophyte infections","author":"Hay","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.210069-19","first-page":"3","volume-title":"An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis","author":"Arca","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0019-5154.210069-20","first-page":"684","volume-title":"One-week therapy with oral terbinafine in cases of tinea cruris\/corporis","author":"Farag","year":"1994","journal-title":"Br J Dermatol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:35:17Z","timestamp":1786714517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_191_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["210069"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_191_17","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}